The Investment Capital Growth Blog

Welcome To The ICG Blog

Strategic Insights For Business Leaders & Their Teams

Investment Capital Growth is dedicated to the personal and professional development of C-Level Executives and the management teams that run modern business. Our blog shares insights and strategies culled from years of entrepreneural and executive experience. Our thought leaders regularly publish business articles to inspire and empower.

Get Inspired, Stay Connected:

  • Subscribe To Our Blog For Updates
  • Follow ICG on Social Media
  • Engage Our Consultants

Subscribe To The ICG Blog

Oops! We could not locate your form.

Posts by Topic

Learn about continuous, ultra-cheap, personalized, and proactive healthcare

Posted by Cliff Locks On December 11, 2019 at 10:36 am / In: Uncategorized

Learn about continuous, ultra-cheap, personalized, and proactive healthcare

The U.S. healthcare industry is in for a major disruption in the decade ahead.

It is so broken, that it’s horrifying.

U.S. healthcare spending is expected to hit a total of US$3.6 trillion in 2019.

Fear of liability prompts U.S. doctors to spend US$210 billion per year on procedures patients don’t need.

Of every 5,000 new drugs introduced, 5 make it to human testing, and only one is ultimately approved. Yet even then, the average pharmaceutical product takes 12 YEARS to get from lab to patient, costing upwards of $2.5 billion.

Over the next five blogs, we’ll be diving into the digital medicine and biotech revolution unfolding before us. A new generation of AI-enabled, data-driven companies will transform what is today “sick care” into healthcare.

In this blog, we’ll look at a new generation of diagnostics that enable you to become the CEO of your own health. Ultimately, how you can catch disease at “stage-0” before it becomes life threatening.

Let’s dive in…

Continuous DIY Diagnostics

On a wintery Wednesday in January 2026, you’re being watched. Carefully watched.

Technically, you’re asleep in your bed, but Google’s home assistant knows your schedule. Thanks to your Oura ring, it also knows you’ve just completed a REM cycle and are now entering Stage 1 sleep—making it the perfect time to wake you up.

A gentle increase in the room’s lighting simulates the sunrise, while optimized light wavelengths maximize wakefulness and improve your mood.

“Hey Google, how’s my health this morning?” “One moment,” says your digital assistant.

It takes thirty seconds for the full diagnostic to run, which is pretty good considering the system deploys dozens of sensors capturing gigabytes of data.

Smart sensors in toothbrush and toilet, wearables in bedding and clothing, implantables inside your body—a mobile health suite with a 360-degree view of your system. “Your microbiome looks perfect,” Google tells you. “Also, blood glucose levels are good, vitamin levels fine…”

Google is developing a full range of internal and external sensors that monitor everything from blood sugar to blood chemistry.

And that’s just Google. The list of once multimillion-dollar medical machines now being dematerialized, demonetized, democratized, and delocalized—that is, made into portable and even wearable sensors—could fill a textbook.

Consider the spectrum of possibilities.

On the whiz-bang side, there’s Exo’s AI-enabled, cheap, handheld ultrasound 3D imager—meaning you will soon be able to track anything from wound-healing to fetus growth from the comfort of your home.

Or take former Google X project leader Mary Lou Jepsen’s startup, Openwater, which uses red laser holography to create a portable MRI (magnetic resonance imaging), turning what is today a multimillion-dollar machine into a wearable consumer electronics device. With successful rollout, products like that of Openwater could soon give three-quarters of the world access to medical imaging they currently lack.

Yet simpler developments might be more revolutionary.

In less than two decades, wearables have gone from first-generation step-counting self-trackers to Apple’s fourth-generation iWatch, which includes an FDA-approved ECG scanner capable of real-time cardiac monitoring.

Or look at Final Frontier Medical Devices’ DxtER (winner of the $10 million Qualcomm Tricorder XPRIZE): a collection of easy-to-use, noninvasive medical sensors, and a diagnostic AI, accessible via app. Already, DxtER reliably detects over fifty common ailments.

In convergence, these developments point towards a future of always-on health monitoring and cheap, easy diagnostics.

The technical term for this shift is “mobile health,” a field predicted to explode into a $102 billion market by 2022. Step aside, WebMD. The idea here is to put a virtual doctor, on demand, in your back pocket.

And we’re getting close.

Riding the convergence of networks, sensors, and computing, AI-backed medical chatbots are now flooding the market. These apps can diagnose everything from a rash to retinopathy.

And it’s not just physical ailments. Woebot is now taking on mental health, delivering cognitive behavioral therapy via Facebook Messenger to patients suffering from depression.

Proactive Healthcare

So where are these trends actually headed?

Take Human Longevity Inc., a company Peter Diamandis, co-founded in 2013. Its key offering, the “Health Nucleus” is an annual, three-hour health scan consisting of whole genome sequencing, whole body MRI, heart and lung CT, echocardiogram, and a slew of clinical blood tests—essentially the most complete picture of health currently available.

This picture is important for two reasons. The first is early disease detection.

In 2018, Human Longevity published stats on its first 1,190 clients. Nine percent of its patients uncovered previously undetected coronary artery disease (the number one killer in the world), 2.5 percent found aneurysms (the number two killer in the world), 2 percent saw tumors—and so forth. In total, a staggering 14.4 percent had significant issues requiring immediate intervention, while 40 percent found a condition that needed long-term monitoring.

The second reason this is important? Everything Human Longevity is measuring and tracking via half-day annual visits will soon come to you on demand. Thanks to always-on, always-watching sensors, your smartphone is about to become your doctor.

From Damage Control to Prevention

Skyrocketing AI capabilities, dematerializing sensors, and next-gen computing power are on the verge of embedding themselves in your wearables, home, future AR devices, and—one day—implantables.

In success, today’s era of lengthy, expensive, and reactive ‘sickcare’—mediated by insurance middlemen—is giving way to continuous, ultra-cheap, personalized, and proactive healthcare.

Soon to own our (technological) doctors (not to mention our health data), we will no longer correct for risk once losses are incurred. Instead, we’ll be minimizing risk 24/7, at extraordinarily low cost, without even thinking about it.

Board of Directors | Board of Advisors | Strategic Leadership

Please keep me in mind as your Executive Coach, openings for Senior Executive Engagements, and Board of Director openings. If you hear of anything within your network that you think might be a positive fit, I’d so appreciate if you could send a heads up my way. Email me: Cliff@InvestmentCapitalGrowth.com or Schedule a call: Cliff Locks

Download Resume

Download Resume (PDF)

#Healthcare #5G #BoardofDirectors #BoD #artificialintelligence #AI #innovation #IoT #virtualreality #vr #AR #augmentedreality #HR #executive #business #CXO #CEO #CFO #CIO #BoardofDirectors #executive doctors #doctor #medical #medicine #health #healthcare #hospital #medstudent #medschool #surgery #medicalschool #surgeon #hospitals #dentist #medicalstudent #futuredoctor #physician Contributors: Peter Diamandis and Clifford Locks #InvestmentCapitalGrowth